Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Febrile Neutropenia × Levofloxacin × Clear all

Phase

Phase 4 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Sezary Syndrome 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neutropenia 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Biphenotypic, Acute 2 Intraocular Lymphoma 2 Infections 2 Immunoblastic Lymphadenopathy 2 Hodgkin Disease 2 Burkitt Lymphoma 2 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Small Cell Lung Carcinoma 1 Ovarian Neoplasms 1 Neoplasms 1 Myelodysplastic Syndromes 1 Mycoses 1 Lung Neoplasms 1

Interventions

pegfilgrastim 2 pegylated granulocyte colony-stimulating factor 1 Vancomycin 1 TKN732 1 Linezolid 1 Levofloxacin 1 Filgrastim 1 Bevacizumab 1 Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03003273 2019-02-01

DALFEN

All India Institute of Medical Sciences

Phase 3 Terminated

Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡